Consortium for Tobacco Use Cessation Technical Assistance financed solely by Prevention and Public Health Funds

 

To provide technical assistance to state tobacco control programs and national and state partners. The technical assistance will focus on translating the science of tobacco control cessation into public health action in order to increase the number of tobacco users in the United States who quit

Deleted 03/27/2024 (Archived.) 93.759 Centers For Disease Control and Prevention, Department of Health and Human Services B - Project Grants Not applicable. For all authorizations/amendments, you must supply the Act or the Executive Order in order to continue Consolidation Appropriations Act, Fiscal Year 2013, Public Law 112-74, for the Department of Labor, Health and Human Services, and Education and the Department of Interior and Related Agencies; and the Consolidated and Further Continuing Appropriations Act, Fiscal Year 2013, Public Law 112-55 for the United States Department of Agriculture, and Related Agencies. Title IV section 4002 Prevention and Public Health Fund. A Bona Fide Agent is an agency/organization identified by the state as eligible to submit an application under the state eligibility in lieu of a state application. If applying as a bona fide agent of a state or local government, a legal, binding agreement from the state or local government as documentation of the status is required The general public will benefit from the objectives of this program. Not applicable. Preapplication coordination is required. This program is eligible for coverage under E.O. 12372, "Intergovernmental Review of Federal Programs." An applicant should consult the office or official designated as the single point of contact in his or her State for more information on the process the State requires to be followed in applying for assistance, if the State has selected the program for review. n/a This program is excluded from coverage under 2 CFR 200, Uniform Administrative Requirements, Cost Principles, and Audit Requirements for Federal Awards. All applications that are complete and responsive to competitive cooperative agreement announcement will undergo an objective review process, receive a written critique and be scored according to published review criteria. Successful applicants will receive a Notice of Award (NoA) from the CDC Procurement and Grants Office. The NOA shall be the only binding, authorizing document between the recipient and CDC. The NoA will be signed by an authorized CDC Grants Management Officer. Contact the headquarters or regional location, as appropriate for application deadlines From 120 to 180 days. Not applicable. From 120 to 180 days. Renewals will be based upon the conditions in the funding announcement and are subject to the availability of funds under Section 317 of the Public Health Service Act or under the Patient Protection and Affordable Care Act. Applications will be reviewed for completeness by the Procurement and Grants Office (PGO) staff and for responsiveness jointly by the National Center for Chronic Disease Prevention and Health Promotion and PGO. Incomplete applications and applications that are non-responsive to the eligibility criteria will not advance through the review process. Applicants will be notified if the application did not meet submission requirements. CDC will conduct a review to evaluate complete and responsive applications according to the criteria listed in Section V. Application Review Information within the individual funding announcement. Applicants will be notified if their application did not meet program requirements. Project funds may be used for costs associated with planning, organizing, conducting, and supporting tobacco cessation technical assistance strategies. CDC will have substantial involvement with the award recipient during performance of the funded activity. Performance Reports: Annual Progress reports are required Not applicable. Not applicable. Statutory formula is not applicable to this assistance listing.

Matching requirements are not applicable to this assistance listing.

MOE requirements are not applicable to this assistance listing. 5-year project period w/12-month budget period Method of awarding/releasing assistance: Lump. None/Not specified. Steve Babb
NCCDPHP, 4770 Buford Highway NE, MSK50
Atlanta, GA 30341 US
SBabb@cdc.gov
Phone: 770-488-1172 75-0943-0-1-550 (Cooperative Agreements) FY 18$450,000.00; FY 19 est $0.00; FY 20 est $0.00; FY 17$450,000.00; FY 16$450,000.00; - This program received a 12-month extension to the Period of Performance. It will end 2019. A new program is being considered to be written to support these activities. This program has received a new assistance listing number to support the new NOFO for FY19. This program was re announced using a non PPHF CFDA number. Not applicable/available. Effective tobacco cessation treatments are available, including group, individual, and telephone counseling and FDA-approved cessation medications. However, less than one third of cigarette smokers use these treatments when trying to quit. Physician cessation interventions increase patient quit rates, but many physicians to not routinely intervene with their patients who use tobacco products. Population-based strategies that increase cessation include, but are not limited to, reducing out-of-pocket costs for evidence-based tobacco cessation treatments (i.e., ensuring that health insurance plans cover these treatments), provider reminder systems in health care settings (including reminders embedded in electronic health records) that prompt health care providers to screen for tobacco use and provide cessation advice, telephone quitlines, and mobile-phone based cessation texting interventions. CDC recommends that state tobacco control programs implement these effective population-based strategies for increasing cessation and put in place a comprehensive plan to address cessation. The Office on Smoking and Health has worked with several national organizations in providing information to state tobacco control programs and national and state partners on OSH's three major cessation priorities: enhancing state quitline capacity and sustainability, promoting comprehensive coverage of evidence-based tobacco cessation treatments in health insurance plans, and promoting health systems changes that improve the rates of tobacco use screening and cessation intervention in health care settings. CDC recommendations regarding cessation activities to be implemented by state tobacco control programs are described in greater depth in CDC's Best Practices for Comprehensive Tobacco Control Programs - 2014 (see http://www.cdc.gov/tobacco/stateandcommunity/best_practices/pdfs/2014/sectionA-III.pdf ). Not applicable.